Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats

BACKGROUND: Alendronate (ALN) is the most common form of bisphosphonates used for the treatment of osteoporosis. Osteoprotegerin (OPG) has also been shown to reduce osteoporotic changes in both humans and experimental animals after systemic administration. The aim of this current study was to test i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Huang, Peng, Tang, Pei-Fu, Chan, Kai-Ming, Li, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143091/
https://www.ncbi.nlm.nih.gov/pubmed/21752290
http://dx.doi.org/10.1186/1749-799X-6-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143091/
https://www.ncbi.nlm.nih.gov/pubmed/21752290
http://dx.doi.org/10.1186/1749-799X-6-34

Ejemplares similares